Title |
Changes in QTc Interval in the Citalopram for Agitation in Alzheimer's Disease (CitAD) Randomized Trial
|
---|---|
Published in |
PLOS ONE, June 2014
|
DOI | 10.1371/journal.pone.0098426 |
Pubmed ID | |
Authors |
Lea T. Drye, David Spragg, D. P. Devanand, Constantine Frangakis, Christopher Marano, Curtis L. Meinert, Jacobo E. Mintzer, Cynthia A. Munro, Gregory Pelton, Bruce G. Pollock, Anton P. Porsteinsson, Peter V. Rabins, Paul B. Rosenberg, Lon S. Schneider, David M. Shade, Daniel Weintraub, Jerome Yesavage, Constantine G. Lyketsos |
Abstract |
A Food and Drug Administration (FDA) safety communication in August 2011 warned that citalopram was associated with a dose dependent risk of QT prolongation and recommended dose restriction in patients over the age of 60 but did not provide data for this age group. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 2 | 67% |
Scientists | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 139 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | <1% |
Unknown | 138 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 24 | 17% |
Researcher | 17 | 12% |
Student > Bachelor | 16 | 12% |
Other | 15 | 11% |
Student > Postgraduate | 8 | 6% |
Other | 26 | 19% |
Unknown | 33 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 42 | 30% |
Neuroscience | 10 | 7% |
Nursing and Health Professions | 9 | 6% |
Psychology | 8 | 6% |
Agricultural and Biological Sciences | 6 | 4% |
Other | 25 | 18% |
Unknown | 39 | 28% |